Valens Semiconductor SVP sells shares Nov. 10–11

Available on EDGAR 11/12/2026 - 07:51 AM EST Accepted by SEC EDGAR 11/12/2026 - 07:50 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

David Chairman, Valens Semiconductor Ltd.'s SVP, R&D, exercised options to acquire 3,235 ordinary shares on November 10, 2026, and 278 ordinary shares on November 11, 2026, at an exercise price of $0.86 per share; he sold those shares on the same dates. The November 10 sale price was a $1.6635 weighted average, with transactions ranging from $1.66 to $1.6684 per share; the November 11 sale price was $1.66 per share. The sales were made under a Rule 10b5-1 trading plan adopted June 1, 2026.

Insider Trade Summary 10b5-1

Exercise and Sale: 3,513 shares ($3K approx. pre-tax spread)

Exercise and Sale 6 txns

Insider Chairman David

Role SVP, R&D

Sold 3,513 shs ($6K)

Approx. gross sale proceeds $6K

Approx. exercise cost $3K

Approx. pre-tax spread $3K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F2	278	$0.00	$0.00
Exercise	Ordinary Shares F1, F3	278	$0.86	$239.08
Sale	Ordinary Shares F1, F4	278	$1.66	$461.48
Exercise	Stock Option (Right to Buy) F2	3,235	$0.00	$0.00
Exercise	Ordinary Shares F1, F3	3,235	$0.86	$3K
Sale	Ordinary Shares F1, F4, F5	3,235	$1.6635	$5K

Holdings After Transaction: Stock Option (Right to Buy) — 72,182 options (Direct); Ordinary Shares — 403,968 shares (Direct)

Footnotes (5)

1. F1. The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 01, 2026
2. F2. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.
3. F3. The shares were acquired upon the exercise of stock options
4. F4. The shares sold were acquired upon the exercise of stock options on the same date
5. F5. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.66 to $1.6684. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request

Key Figures

Shares acquired on option exercise: 3,235 shares Shares acquired on option exercise: 278 shares Option exercise price: $0.86 per share +3 more

6 metrics

Shares acquired on option exercise 3,235 shares November 10, 2026

Shares acquired on option exercise 278 shares November 11, 2026

Option exercise price $0.86 per share Options exercised on November 10 and November 11, 2026

Weighted average sale price $1.6635 per share November 10, 2026

Sale price range $1.66 to $1.6684 per share November 10, 2026

Sale price $1.66 per share November 11, 2026

Key Terms

Rule 10b5-1 trading plan, weighted average price, Stock Option (Right to Buy)

3 terms

Rule 10b5-1 trading plan regulatory

"pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VLN shares did David Chairman sell, and at what prices?

David Chairman sold 3,235 ordinary shares on November 10, 2026, at a weighted average of $1.6635 per share, and 278 ordinary shares on November 11, 2026, at $1.66 per share. The November 10 transactions ranged from $1.66 to $1.6684 per share, and both sales were made under a Rule 10b5-1 plan adopted June 1, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chairman David

(Last) (First) (Middle)

42 HOLOT GEULIM

(Street)

ZORAN

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Valens Semiconductor Ltd. [ VLN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, R&D

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	11/10/2026		M(1)		3,235(3)	A	$0.86	407,203	D
Ordinary Shares	11/10/2026		S(1)		3,235(4)	D	$1.6635(5)	403,968	D
Ordinary Shares	11/11/2026		M(1)		278(3)	A	$0.86	404,246	D
Ordinary Shares	11/11/2026		S(1)		278(4)	D	$1.66	403,968	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.86	11/10/2026		M(2)			3,235	06/01/2022	06/09/2031	Ordinary Shares	3,235	$0	72,460	D
Stock Option (Right to Buy)	$0.86	11/11/2026		M(2)			278	06/01/2022	06/09/2031	Ordinary Shares	278	$0	72,182	D

Explanation of Responses:

1. The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 01, 2026

2. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.

3. The shares were acquired upon the exercise of stock options

4. The shares sold were acquired upon the exercise of stock options on the same date

5. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.66 to $1.6684. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request

	/s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact	11/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)